Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1998;82:523-531

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tang, H.
Right arrow Articles by Inagami, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, H.
Right arrow Articles by Inagami, T.
(Circulation Research. 1998;82:523-531.)
© 1998 American Heart Association, Inc.


Original Contributions

Role of Cytoplasmic Tail of the Type 1A Angiotensin II Receptor in Agonist– and Phorbol Ester–Induced Desensitization

Hua Tang, Deng Fu Guo, James P. Porter, Yoshio Wanaka, , Tadashi Inagami

From the Department of Biochemistry (H.T., D.F.G., Y.W., T.I.), Vanderbilt University School of Medicine, Nashville, Tenn, and the Department of Physiology and Biophysics (J.P.P.), University of Louisville (Ky).

Correspondence to Tadashi Inagami, PhD, Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232.

Abstract—To investigate mechanisms underlying the agonist-induced desensitization of the type 1A angiotensin II receptor (AT1A-R), we have stably expressed in Chinese hamster ovary (CHO) cells the wild-type receptor and truncated mutants lacking varying lengths of the cytoplasmic tail. Assay of inositol 1,4,5-trisphosphate (IP3) formation in response to agonist demonstrated that the truncated mutants T318, T328, and T348 lacking the last 42, 32, or 12 amino acid residues, respectively, couple with Gq protein with an efficiency similar to that of full-length receptors, whereas coupling of Gq protein was abolished in the T310 truncated mutant devoid of the carboxyl-terminal 50 amino acids. Exposure of CHO/AT1A-R cells expressing the wild-type AT1A-R to angiotensin II resulted in rapid and dose-dependent homologous desensitization of receptor-mediated IP3 formation, which was independent of the receptor internalization. Mastoparan, an activator of G protein–coupled receptor kinase (GRK), induced desensitization of the AT1A-R. The agonist-induced desensitization of the receptor was largely prevented by heparin, a potent inhibitor of GRK, whereas it was only partially attenuated by a protein kinase C (PKC)-specific inhibitor. The homologous or heterologous desensitization of the receptor was greatly impaired in the truncated mutants T318 and T328, lacking the Ser/Thr-rich (13 or 12 Ser/Thr residues) cytoplasmic tail of the AT1A-R. Deletion of the last two Ser residues, including one PKC consensus site in the receptor tail, prevented only phorbol 12-myristate 13-acetate–induced desensitization by 30%. Moreover, we found an agonist-induced translocation of a heparin-sensitive kinase activity. The angiotensin II–stimulated heparin-sensitive kinase could phosphorylate a thioredoxin fusion protein containing the entire AT1A-R cytoplasmic tail (N295 to E359), which lacks consensus phosphorylation sites for GRK1, GRK2, and GRK3. The heparin-sensitive kinase may not be GRK2, GRK3, or GRK6 expressed in CHO/AT1A-R cells, since angiotensin II did not induce translocation of these receptor kinases. Potential Ser/Thr phosphorylation sites located between S328 and S347 in the cytoplasmic tail of AT1A-R seem to play a critical role in the heterologous and homologous desensitization of the receptor. A heparin-sensitive kinase other than GRK2, GRK3, or GRK6 may be involved in the agonist-induced homologous desensitization of the AT1A-R.


Key Words: angiotensin II • desensitization • AT1A receptor • phorbol ester




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Morinelli, R. T. Kendall, L. M. Luttrell, L. P. Walker, and M. E. Ullian
Angiotensin II-Induced Cyclooxygenase 2 Expression in Rat Aorta Vascular Smooth Muscle Cells Does Not Require Heterotrimeric G Protein Activation
J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 118 - 124.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L.-J. Min, M. Mogi, J. Iwanami, J.-M. Li, A. Sakata, T. Fujita, K. Tsukuda, M. Iwai, and M. Horiuchi
Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence
Cardiovasc Res, December 1, 2007; 76(3): 506 - 516.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J.-M. Li, M. Mogi, K. Tsukuda, H. Tomochika, J. Iwanami, L.-J. Min, C. Nahmias, M. Iwai, and M. Horiuchi
Angiotensin II-Induced Neural Differentiation via Angiotensin II Type 2 (AT2) Receptor-MMS2 Cascade Involving Interaction between AT2 Receptor-Interacting Protein and Src Homology 2 Domain-Containing Protein-Tyrosine Phosphatase 1
Mol. Endocrinol., February 1, 2007; 21(2): 499 - 511.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Violin, S. M. DeWire, W. G. Barnes, and R. J. Lefkowitz
G Protein-coupled Receptor Kinase and beta-Arrestin-mediated Desensitization of the Angiotensin II Type 1A Receptor Elucidated by Diacylglycerol Dynamics
J. Biol. Chem., November 24, 2006; 281(47): 36411 - 36419.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Oshita, M. Iwai, R. Chen, A. Ide, M. Okumura, S. Fukunaga, T. Yoshii, M. Mogi, J. Higaki, and M. Horiuchi
Attenuation of Inflammatory Vascular Remodeling by Angiotensin II Type 1 Receptor-Associated Protein
Hypertension, October 1, 2006; 48(4): 671 - 676.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Policha, N. Daneshtalab, L. Chen, L. B. Dale, C. Altier, H. Khosravani, W. G. Thomas, G. W. Zamponi, and S. S. G. Ferguson
Role of Angiotensin II Type 1A Receptor Phosphorylation, Phospholipase D, and Extracellular Calcium in Isoform-specific Protein Kinase C Membrane Translocation Responses
J. Biol. Chem., September 8, 2006; 281(36): 26340 - 26349.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D.-F. Guo, I. Chenier, J. L. Lavoie, J. S.D. Chan, P. Hamet, J. Tremblay, X. M. Chen, D. H. Wang, and T. Inagami
Development of Hypertension and Kidney Hypertrophy in Transgenic Mice Overexpressing ARAP1 Gene in the Kidney
Hypertension, September 1, 2006; 48(3): 453 - 459.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Canals, L. Jenkins, E. Kellett, and G. Milligan
Up-regulation of the Angiotensin II Type 1 Receptor by the MAS Proto-oncogene Is Due to Constitutive Activation of Gq/G11 by MAS
J. Biol. Chem., June 16, 2006; 281(24): 16757 - 16767.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G.-D. Wang, X.-Y. Wang, H.-Z. Hu, X.-C. Fang, S. Liu, N. Gao, Y. Xia, and J. D. Wood
Angiotensin receptors and actions in guinea pig enteric nervous system
Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G614 - G626.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. Teli, D. Markovic, M. A. Levine, E. W. Hillhouse, and D. K. Grammatopoulos
Regulation of Corticotropin-Releasing Hormone Receptor Type 1{alpha} Signaling: Structural Determinants for G Protein-Coupled Receptor Kinase-Mediated Phosphorylation and Agonist-Mediated Desensitization
Mol. Endocrinol., February 1, 2005; 19(2): 474 - 490.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D.-F. Guo, V. Tardif, K. Ghelima, J. S. D. Chan, J. R. Ingelfinger, X. Chen, and I. Chenier
A Novel Angiotensin II Type 1 Receptor-associated Protein Induces Cellular Hypertrophy in Rat Vascular Smooth Muscle and Renal Proximal Tubular Cells
J. Biol. Chem., May 14, 2004; 279(20): 21109 - 21120.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
K. D. Little, M. E. Hemler, and C. S. Stipp
Dynamic Regulation of a GPCR-Tetraspanin-G Protein Complex on Intact Cells: Central Role of CD81 in Facilitating GPR56-G{alpha}q/11 Association
Mol. Biol. Cell, May 1, 2004; 15(5): 2375 - 2387.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. SPAT and L. HUNYADY
Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways
Physiol Rev, April 1, 2004; 84(2): 489 - 539.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. N. McLaughlin, C. D. Thulin, S. M. Bray, M. M. Martin, T. S. Elton, and B. M. Willardson
Regulation of Angiotensin II-induced G Protein Signaling by Phosducin-like Protein
J. Biol. Chem., September 13, 2002; 277(38): 34885 - 34895.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. H. Shah, J. Alberto Olivares-Reyes, A. Yesilkaya, and K. J. Catt
Independence of Angiotensin II-Induced MAP Kinase Activation from Angiotensin Type 1 Receptor Internalization in Clone 9 Hepatocytes
Mol. Endocrinol., March 1, 2002; 16(3): 610 - 620.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. A. W. Tawfeek, F. Qian, and A. B. Abou-Samra
Phosphorylation of the Receptor for PTH and PTHrP Is Required for Internalization and Regulates Receptor Signaling
Mol. Endocrinol., January 1, 2002; 16(1): 1 - 13.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Qian, L. Pipolo, and W. G. Thomas
Association of {beta}-Arrestin 1 with the Type 1A Angiotensin II Receptor Involves Phosphorylation of the Receptor Carboxyl Terminus and Correlates with Receptor Internalization
Mol. Endocrinol., October 1, 2001; 15(10): 1706 - 1719.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
O. Dery, K. A. Defea, and N. W. Bunnett
Protein kinase C-mediated desensitization of the neurokinin 1 receptor
Am J Physiol Cell Physiol, May 1, 2001; 280(5): C1097 - C1106.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. S. G. Ferguson
Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling
Pharmacol. Rev., March 1, 2001; 53(1): 1 - 24.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. García-Caballero, J. A. Olivares-Reyes, K. J. Catt, and J. A. García-Saínz
Angiotensin AT1 Receptor Phosphorylation and Desensitization in a Hepatic Cell Line. Roles of Protein Kinase C and Phosphoinositide 3-Kinase
Mol. Pharmacol., March 1, 2001; 59(3): 576 - 585.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Gonzalez Iglesias, C. Suarez, C. Feierstein, G. Diaz-Torga, and D. Becu-Villalobos
Desensitization of angiotensin II: effect on [Ca2+]i, inositol triphosphate, and prolactin in pituitary cells
Am J Physiol Endocrinol Metab, March 1, 2001; 280(3): E462 - E470.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. G. Meszaros, R. Raphael, F. M. Lio, and L. L. Brunton
Protein kinase C contributes to desensitization of ANG II signaling in adult rat cardiac fibroblasts
Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1978 - C1985.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Tang, T. Nishishita, T. Fitzgerald, E. J. Landon, and T. Inagami
Inhibition of AT1 Receptor Internalization by Concanavalin A Blocks Angiotensin II-induced ERK Activation in Vascular Smooth Muscle Cells. INVOLVEMENT OF EPIDERMAL GROWTH FACTOR RECEPTOR PROTEOLYSIS BUT NOT AT1 RECEPTOR INTERNALIZATION
J. Biol. Chem., April 28, 2000; 275(18): 13420 - 13426.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Tang, Z. J. Zhao, E. J. Landon, and T. Inagami
Regulation of Calcium-sensitive Tyrosine Kinase Pyk2 by Angiotensin II in Endothelial Cells. ROLES OF Yes TYROSINE KINASE AND TYROSINE PHOSPHATASE SHP-2
J. Biol. Chem., March 17, 2000; 275(12): 8389 - 8396.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Daviet, J. Y. A. Lehtonen, K. Tamura, D. P. Griese, M. Horiuchi, and V. J. Dzau
Cloning and Characterization of ATRAP, a Novel Protein That Interacts with the Angiotensin II Type 1 Receptor
J. Biol. Chem., June 11, 1999; 274(24): 17058 - 17062.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Adams, T. S. Obertone, X. Wang, and T. J. Murphy
Relationship between Internalization and mRNA Decay in Down-Regulation of Recombinant Type 1 Angiotensin II Receptor (AT1) Expression in Smooth Muscle Cells
Mol. Pharmacol., June 1, 1999; 55(6): 1028 - 1036.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Satoh, K. Ichihara, E. J. Landon, T. Inagami, and H. Tang
3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Block Calcium-dependent Tyrosine Kinase Pyk2 Activation by Angiotensin II in Vascular Endothelial Cells. INVOLVEMENT OF GERANYLGERANYLATION OF SMALL G PROTEIN Rap1
J. Biol. Chem., May 4, 2001; 276(19): 15761 - 15767.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Olivares-Reyes, R. D. Smith, L. Hunyady, B. H. Shah, and K. J. Catt
Agonist-induced Signaling, Desensitization, and Internalization of a Phosphorylation-deficient AT1A Angiotensin Receptor
J. Biol. Chem., October 5, 2001; 276(41): 37761 - 37768.
[Abstract] [Full Text] [PDF]